×

Genentech's Positive Results

7:42 AM ET Mon, 4 June 2007

Genentech has achieved positive results from the phase 3 study of its Avastin drug, with Susan Desmond-Hellmann, Genentech president of product development and CNBC's Mike Huckman, Becky Quick, & Joe Kernen